Evexia Diagnostics now offers 20/20 BioLabs’ OneTest™ MCED test, giving clinicians affordable, biomarker insights for ...

The new test removes the need for patients to have to undergo physical examinations, scans and biopsies to see if cancer has ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats that consumers should understand.

Current tests for endometrial cancer often rely on procedures like transvaginal ultrasound and tissue biopsy to evaluate the ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.

When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...

Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

A Miami man credits a routine blood test with saving his life after early-stage colon cancer was found via colonoscopy, ...

A bill requiring state-run insurance plans to pay for biomarker testing passed committee in an 8-1 vote today at the ...